Anton Dobrin

3.6k citations
15 papers · 2.7k · 2 hit papers · h-index 12

Impact in

  • Oncology top 1%
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers
    • Pancreatic and Hepatic Oncology Research
  • Immunology top 2%
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology
    • Immune Cell Function and Interaction

Papers in

    • CAR-T cell therapy research 10
    • Cancer Immunotherapy and Biomarkers 4
    • T-cell and B-cell Immunology 1
    • Immunotherapy and Immune Responses 1

Anton Dobrin

14 papers receiving 2.7k citations

Anton Dobrin's Hit Papers

Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer 2023 · 1k citations
1k0+2+4Years since publication2505007501k

Peers

Anton Dobrin
Comparison fields: 5 of 70
  • Oncology 1.8k
  • Immunology 766
  • Molecular Biology 397
  • Physiology 17
  • Cancer Research 56
Replace Katherine A. Alexander with:
Katherine A. Alexander United States
Stefano Sammicheli Sweden
Junyun Lai Australia
Xiao‐Tong Song United States
Hans Vitzthum United States
Jean-Pierre Eliane United States
Patrick Yan United States
Joyce Chen United States
Stefanie Lesch Germany
Lenka Kašíková Czechia
Anton Dobrin relative to Katherine A. Alexander United States Katherine A. Alexander's profile →
Citations per field
00.5×1.5×2×2.4×
Katherine A. Alexander · 1×
Citations per year

Countries citing papers authored by Anton Dobrin

Since Specialization
Citations

This map shows the geographic impact of Anton Dobrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton Dobrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton Dobrin more than expected).

Fields of papers citing papers by Anton Dobrin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anton Dobrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton Dobrin. The network helps show where Anton Dobrin may publish in the future.

Co-authors

The 25 scholars most cited alongside Anton Dobrin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anton Dobrin Line = papers co-authored together Anton Dobrin links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
Hit paper breakdown →
20231009
2
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape
Hit paper breakdown →
2019545
3 2018448
4 2022157
5 2022154
6 2023119
7 202285
8 202370
9 202457
10 201739
11 201519
12 202516
13 202412
14 20251
15 20260

About Anton Dobrin

Anton Dobrin is a scholar working on Oncology, Immunology, Cancer Research, Molecular Biology and Nuclear Energy and Engineering, having authored 15 papers that have together received 2.7k indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), Cancer Immunotherapy and Biomarkers (4 papers), T-cell and B-cell Immunology (1 paper), Gene Regulatory Network Analysis (1 paper), Cancer Genomics and Diagnostics (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Oncology (1.8k citations), Immunology (766 citations), Molecular Biology (397 citations), Physiology (17 citations) and Cancer Research (56 citations). Anton Dobrin has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Michel Sadelain, Zeguo Zhao, Mohamad Hamieh, Justin Eyquem, Annalisa Cabriolu, Judith Feucht, Josef Leibold, Yu-Jui Ho, Jie Sun and Jorge Mansilla‐Soto. Their work appears in journals such as Nature, Nature Medicine, Science Immunology, Integrative Biology and Molecular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact